Back to Newsroom

Conatus to Present at BIO CEO & Investor Conference

SAN DIEGO, Feb. 06, 2017 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) today announced its scheduled presentation to provide an overview of the company’s programs and outlook at the Biotechnology Industry Organization (BIO) CEO & Investor Conference in New York at 2:30 p.m. ET on Monday, February 13, 2017. An audio webcast and copy of the presentation will be available in the Investors section of the company’s website at www.conatuspharma.com.

Click here to read the full release